JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHA:600200)

SHA:600200 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,472	1,580	2,224	2,026	1,761	1,858
Other Revenue	18.6	18.6	15.76	-	14.65	13.57
Revenue	1,490	1,599	2,240	2,026	1,775	1,872
Revenue Growth (YoY)	-27.43%	-28.64%	10.55%	14.12%	-5.14%	-11.29%
Cost of Revenue	666.4	829.46	1,698	1,448	1,270	1,300
Gross Profit	823.88	769.05	542.17	578.14	505.18	571.51
Selling, General & Admin	619.05	581.46	519.84	564.92	519.41	574.79
Research & Development	63.16	61.12	39.28	28.56	21.09	37.48
Other Operating Expenses	26.68	20.39	14.16	14.34	12.02	1.39
Operating Expenses	806.41	665.58	574.13	606.46	553.91	647.08
Operating Income	17.47	103.46	-31.96	-28.33	-48.73	-75.57
Interest Expense	-66.2	-71.83	-76.34	-74.6	-64.56	-64.42
Interest & Investment Income	18.66	14.72	33.9	16.73	20.11	21.01
Currency Exchange Gain (Loss)	0.35	0.35	-0.13	-0.15	-0.01	-0.01
Other Non Operating Income (Expenses)	-9.9	-7.37	2.01	-1.47	-0.37	-49.41
EBT Excluding Unusual Items	-39.63	39.33	-72.52	-87.81	-93.56	-168.4
Impairment of Goodwill	-	-	-	-	-	-12.59
Gain (Loss) on Sale of Investments	1.23	-	-	-	-	0.13
Gain (Loss) on Sale of Assets	-0.02	-0.14	-0.89	0.16	100.11	-2.64
Asset Writedown	-1.18	-0.8	-	-	4.9	-341.1
Other Unusual Items	16.76	16.73	2.22	12.25	27.79	4.28
Pretax Income	-22.84	55.12	-71.19	-75.4	39.24	-504.12
Income Tax Expense	-29.31	-21.84	3.26	2.91	18.6	3.47
Earnings From Continuing Operations	6.47	76.96	-74.45	-78.32	20.64	-507.6
Minority Interest in Earnings	-11.37	-6.48	2.51	2.05	2.08	1.18
Net Income	-4.89	70.48	-71.95	-76.27	22.72	-506.41
Net Income to Common	-4.89	70.48	-71.95	-76.27	22.72	-506.41
Shares Outstanding (Basic)	709	712	712	713	710	713
Shares Outstanding (Diluted)	709	712	712	713	710	713
Shares Change (YoY)	-1.15%	-0.05%	-0.07%	0.41%	-0.47%	-0.53%
EPS (Basic)	-0.01	0.10	-0.10	-0.11	0.03	-0.71
EPS (Diluted)	-0.01	0.10	-0.10	-0.11	0.03	-0.71
Free Cash Flow	-1,237	-309.96	-286.26	14.55	422.83	-458.81
Free Cash Flow Per Share	-1.75	-0.43	-0.40	0.02	0.60	-0.64
Gross Margin	55.28%	48.11%	24.20%	28.53%	28.45%	30.53%
Operating Margin	1.17%	6.47%	-1.43%	-1.40%	-2.74%	-4.04%
Profit Margin	-0.33%	4.41%	-3.21%	-3.76%	1.28%	-27.06%
Free Cash Flow Margin	-83.01%	-19.39%	-12.78%	0.72%	23.82%	-24.51%
EBITDA	64.85	150.35	12.94	18.34	0.02	7.87
EBITDA Margin	4.35%	9.41%	0.58%	0.91%	0.00%	0.42%
D&A For EBITDA	47.38	46.89	44.9	46.67	48.75	83.44
EBIT	17.47	103.46	-31.96	-28.33	-48.73	-75.57
EBIT Margin	1.17%	6.47%	-1.43%	-1.40%	-2.74%	-4.04%
Effective Tax Rate	-	-	-	-	47.40%	-
Revenue as Reported	1,490	1,599	2,240	2,026	1,775	-
Advertising Expenses	-	345.06	330.75	380.76	335.15	366.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.